Analysis of prognostic factors and treatment of modality changes in breast cancer: A single institution study in Korea

Yonsei Medical Journal

Volumn 48, Issue 3, 2007, Pages 465-473

  Lee, Won Suk ^a   Lee, Jeong Eon ^a   Kim, Jung Han ^a   Nam, Seok Jin ^a   Yang, Jung Hyun ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Breast cancer; Breast conserving surgery; Disease free survival; Survival

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROGESTERONE RECEPTOR;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER INVASION; CANCER SURGERY; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; KOREA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDICAL RECORD; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PATIENT MONITORING; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; KOREA; MASTECTOMY; MASTECTOMY, SEGMENTAL; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 34447547537     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2007.48.3.465     Document Type: Article

References (23)

1. National Statistical Office. Annual Report on the Causes Death Statistics. Seoul, Republic of Korea; 2003.
2. National Cancer Center. Annual Report of Cancer Registry. Seoul, Republic of Korea; 2002.
3. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer Incidence in Five Continents. Lyon, France: International Agency for Research on Cancer; 2002.
4. Korean Breast Cancer Society. Korean breast cancer data of 1996. J Korean Surg Soc 1998;55:621-35.
5. Greene FL, Page DL, Fleming ID, Fritz AG, Batch CM, Haller DG, et al. AJCC cancer staging manual. New York: Springer-Valag; 2002 p.255-82.
6. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991;19:403-10.
7. Oh YL, Choi J5, Song SY, Ko YH, Han BK, Nam SJ, et al. Expression of p21Waf1, p27Kip1 and cyclin D1 proteins in breast ductal carcinoma in situ: Relation with clinicopathologic characteristics and with p53 expression and estrogen receptor status. Pathol Int 2001; 51:94-9.
8. Allred DC, Bustamante MA, Daniel CO, Gaskill HV, Cruz AB Jr. Immunocytochemical analysis of estrogen receptors in human breast carcinomas. Evaluation of 130 cases and review of the literature regarding concordance with biochemical assay and clinical relevance. Arch Surg 1990;125:107-13.
9. Campbell JB. Breast cancer-race, ethnicity, and survival: a literature review. Breast Cancer Res Treat 2002;74:187-92.
10. Hsu JL, Glaser SL, West DW. Racial/ethnic differences in breast cancer survival among San Francisco Bay Area women. J Natl Cancer Inst 1997;89:1311-2.
11. Eley JW, Hill HA, Chen VW, Austin DF, Wesley MN, Muss HB, et al. Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA 1994;272:947-54.
12. The Korean Breast Cancer Society. Clinical characteristics of Korean breast cancer patients in 1998. J Korean Med Sci 2000;15:569-79.
13. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1997. CA Cancer J Clin 1997;47:5-27.
14. Yancik R, Ries LG, Yates JW. Breast cancer in aging women. A population-based study of contrasts in stage, surgery, and survival. Cancer 1989;63:976-81.
15. Harris JR, Lippman ME, Morrow M, Hellman S. Disease of the Breast. Philadelphia: Lippincott-Raven; 1996. p.160.
16. Wyld L, Reed MW. The need for targeted research into breast cancer in the elderly. Br J Surg 2003;90:388-99.
17. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347: 1233-41.
18. NIH consensus conference. Treatment of early-stage breast cancer. JAMA 1991;265:391-5.
19. Son BH, Yoon HS, Kwak HS, Lee PC, Ko KB, Kim JS, et al. Clinical analysis of breast cancer surgeries in Korea. J Korean Surg Soc 2001;60:470-6.
20. Bland KI, Menck HR, Scott-Conner CE, Morrow M, Winchester DJ, Winchester DP. The National Cancer Data Base 10-year survey of breast carcinoma treatment at hospitals in the United States. Cancer 1998;83:1262-73.
21. Kim KJ, Huh SJ, Yang JH, Park W, Nam SJ, Kim JH, et al. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy. Jpn J Clin Oncol 2005;35:126-33.
22. Cheng SH, Tsou MH, Liu MC, Jian JJ, Cheng JC, Leu SY, et al. Unique features of breast cancer in Taiwan. Breast Cancer Res Treat 2000;63:213-23.
23. Fisher ER, Anderson S, Redmond C, Fisher B. Pathologic findings from the National Surgical Adjuvant Breast Project protocol B-06. 10-year pathologic and clinical prognostic discriminants. Cancer 1993;71:2507-14.